BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35090033)

  • 1. Inflammation and physical dysfunction: responses to moderate intensity exercise in chronic kidney disease.
    Watson EL; Baker LA; Wilkinson TJ; Gould DW; Xenophontos S; Graham-Brown M; Major RW; Ashford RU; Viana JL; Smith AC
    Nephrol Dial Transplant; 2022 Apr; 37(5):860-868. PubMed ID: 35090033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-week combined resistance and aerobic training confers greater benefits than aerobic training alone in nondialysis CKD.
    Watson EL; Gould DW; Wilkinson TJ; Xenophontos S; Clarke AL; Vogt BP; Viana JL; Smith AC
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1188-F1196. PubMed ID: 29412705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality over quantity? Association of skeletal muscle myosteatosis and myofibrosis on physical function in chronic kidney disease.
    Wilkinson TJ; Gould DW; Nixon DGD; Watson EL; Smith AC
    Nephrol Dial Transplant; 2019 Aug; 34(8):1344-1353. PubMed ID: 29939315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive Resistance Exercise Training in CKD: A Feasibility Study.
    Watson EL; Greening NJ; Viana JL; Aulakh J; Bodicoat DH; Barratt J; Feehally J; Smith AC
    Am J Kidney Dis; 2015 Aug; 66(2):249-57. PubMed ID: 25533601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductions in skeletal muscle mitochondrial mass are not restored following exercise training in patients with chronic kidney disease.
    Watson EL; Baker LA; Wilkinson TJ; Gould DW; Graham-Brown MPM; Major RW; Ashford RU; Philp A; Smith AC
    FASEB J; 2020 Jan; 34(1):1755-1767. PubMed ID: 31914685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle mass and plasma myostatin after exercise training: a substudy of Renal Exercise (RENEXC)-a randomized controlled trial.
    Zhou Y; Hellberg M; Hellmark T; Höglund P; Clyne N
    Nephrol Dial Transplant; 2021 Jan; 36(1):95-103. PubMed ID: 31848626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myostatin and muscle atrophy during chronic kidney disease.
    Bataille S; Chauveau P; Fouque D; Aparicio M; Koppe L
    Nephrol Dial Transplant; 2021 Nov; 36(11):1986-1993. PubMed ID: 32974666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical exercise in kidney disease: A commonly undervalued treatment modality.
    Kanbay M; Copur S; Yildiz AB; Tanriover C; Mallamaci F; Zoccali C
    Eur J Clin Invest; 2024 Feb; 54(2):e14105. PubMed ID: 37814427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association of muscle size, strength and exercise capacity with all-cause mortality in non-dialysis-dependent CKD patients.
    Watson EL; Major RW; Wilkinson TJ; Greening NJ; Gould DW; Barratt J; Smith AC
    Clin Physiol Funct Imaging; 2020 Nov; 40(6):399-406. PubMed ID: 32772507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Relationship Between Myostatin, Inflammatory Markers, and Sarcopenia in Patients With Chronic Kidney Disease.
    Yasar E; Tek NA; Tekbudak MY; Yurtdaş G; Gülbahar Ö; Uyar GÖ; Ural Z; Çelik ÖM; Erten Y
    J Ren Nutr; 2022 Nov; 32(6):677-684. PubMed ID: 35122995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Approaches in Mitochondrial Dysfunction, Inflammation, and Autophagy in Uremic Cachexia: Role of Aerobic Exercise.
    Zhang Y; Liu Y; Bi X; Hu C; Ding F; Ding W
    Mediators Inflamm; 2019; 2019():2789014. PubMed ID: 31530994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential therapeutic interventions for chronic kidney disease-associated sarcopenia via indoxyl sulfate-induced mitochondrial dysfunction.
    Enoki Y; Watanabe H; Arake R; Fujimura R; Ishiodori K; Imafuku T; Nishida K; Sugimoto R; Nagao S; Miyamura S; Ishima Y; Tanaka M; Matsushita K; Komaba H; Fukagawa M; Otagiri M; Maruyama T
    J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):735-747. PubMed ID: 28608457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of aerobic exercise and resistance training in patients with and without chronic kidney disease.
    Moinuddin I; Leehey DJ
    Adv Chronic Kidney Dis; 2008 Jan; 15(1):83-96. PubMed ID: 18155113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper.
    Headley SA; Chapman DJ; Germain MJ; Evans EE; Hutchinson J; Madsen KL; Ikizler TA; Miele EM; Kirton K; O'Neill E; Cornelius A; Martin B; Nindl B; Vaziri ND
    BMC Nephrol; 2020 Nov; 21(1):517. PubMed ID: 33243160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerobic exercise training improves endothelial function and attenuates blood pressure reactivity during maximal exercise in chronic kidney disease.
    Sprick JD; Mammino K; Jeong J; DaCosta DR; Hu Y; Morison DG; Nocera JR; Park J
    J Appl Physiol (1985); 2022 Mar; 132(3):785-793. PubMed ID: 35142559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Nutrition and Exercise on Body Composition, Exercise Capacity, and Physical Functioning in Advanced CKD Patients.
    Ekramzadeh M; Santoro D; Kopple JD
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic exercise capacity is maintained over a 5-year period in mild-to-moderate chronic kidney disease: a longitudinal study.
    Wallin H; Jansson E; Wallquist C; Hylander Rössner B; Jacobson SH; Rickenlund A; Eriksson MJ
    BMC Nephrol; 2020 Nov; 21(1):475. PubMed ID: 33176704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise and CKD: Skeletal Muscle Dysfunction and Practical Application of Exercise to Prevent and Treat Physical Impairments in CKD.
    Roshanravan B; Gamboa J; Wilund K
    Am J Kidney Dis; 2017 Jun; 69(6):837-852. PubMed ID: 28427790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a renal rehabilitation exercise program in patients with CKD: a randomized, controlled trial.
    Rossi AP; Burris DD; Lucas FL; Crocker GA; Wasserman JC
    Clin J Am Soc Nephrol; 2014 Dec; 9(12):2052-8. PubMed ID: 25414318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.
    Yu R; Chen JA; Xu J; Cao J; Wang Y; Thomas SS; Hu Z
    J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):327-341. PubMed ID: 27897418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.